Data / Form D filings / Pharmaceutics International, Inc.
Pharmaceutics International, Inc.: Form D filings
Pharmaceutics International, Inc., a pharmaceuticals company in Hunt Valley, MD, filed 18 Form D notices with the SEC between 2016 and 2024. The latest, on October 23, 2024, reports $11.2 million sold of a $11.2 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10819 GILROY ROAD, Hunt Valley, MD, 21030
- Phone
- (410) 584-0001
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1684470
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 23, 2024 | Amendment | $11,249,998 | $11,249,998 | 3 | Jun 3, 2024 | sec.gov | |
| Jun 11, 2024 | New notice | $8,249,990 | $4,249,990 | $4,000,000 | 3 | Jun 3, 2024 | sec.gov |
| Mar 13, 2024 | New notice | $4,249,989 | $4,249,989 | 6 | Mar 6, 2024 | sec.gov | |
| Jun 27, 2023 | New notice | $12,000,000 | $6,000,000 | $6,000,000 | 2 | Jun 16, 2023 | sec.gov |
| Dec 12, 2022 | New notice | $3,000,159 | $3,000,159 | 5 | Dec 8, 2022 | sec.gov | |
| Oct 7, 2022 | New notice | $9,007,812 | $9,007,812 | 5 | Sep 23, 2022 | sec.gov | |
| Aug 22, 2022 | New notice | $5,000,319 | $5,000,319 | 5 | Aug 8, 2022 | sec.gov | |
| Jul 12, 2022 | New notice | $5,000,319 | $5,000,319 | 5 | Jun 27, 2022 | sec.gov | |
| May 5, 2022 | New notice | $5,000,000 | $5,000,000 | 4 | Apr 27, 2022 | sec.gov | |
| Mar 17, 2022 | New notice | $5,000,319 | $5,000,319 | 4 | Mar 2, 2022 | sec.gov | |
| Jan 11, 2022 | New notice | $5,000,159 | $5,000,159 | 2 | Dec 21, 2021 | sec.gov | |
| Oct 29, 2021 | New notice | $5,000,159 | $5,000,159 | 2 | Oct 14, 2021 | sec.gov | |
| Aug 6, 2021 | New notice | $6,000,000 | $6,000,000 | 5 | Jul 23, 2021 | sec.gov | |
| Jun 4, 2021 | New notice | $10,000,000 | $10,000,000 | 6 | Dec 31, 2020 | sec.gov | |
| Jun 4, 2021 | New notice | $3,000,159 | $3,000,159 | 4 | May 21, 2021 | sec.gov | |
| Oct 29, 2018 | New notice | $15,000,000 | $5,971,142 | $9,028,858 | 5 | Oct 22, 2018 | sec.gov |
| Aug 15, 2017 | New notice | $19,998,885 | $9,999,522 | $9,999,363 | 6 | Aug 3, 2017 | sec.gov |
| Sep 14, 2016 | New notice | $107,999,363 | $107,999,363 | 9 | Aug 31, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David E Solomon | Director | |
| Mark E Kavulich | Director | |
| Syed E Abidi, Ph.D. | Director | |
| John E Fowler | Executive Officer, Director | |
| Michael E Bogda | Director | |
| James E Gale | Director |
Other pharmaceuticals companies in Maryland that filed recently
- Cerium Pharmaceuticals, Inc. $750,000 · Aug 6, 2026
Every Form D from the week of Oct 21, 2024 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Pharmaceutics International, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.